Trump’s latest drug pricing plan may offer benefits to patients, but faces obstacles

The Trump administration’s latest effort to reduce drug prices met with generally positive reviews from policy analysts, who also noted the difficult path ahead to put the plan into effect.
In a speech in October, President Donald J. Trump unveiled his proposal, the International Pricing Index, which would gradually lower drug payment levels to levels based on international prices and set payment amounts for storing and handling drugs that are not be tied to the drug’s cost. The strategy would be phased in over 5 years, apply to 50% of (Read more...)

Full Story →